Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

173 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Metastasis and bone loss: advancing treatment and prevention.
Coleman RE, Lipton A, Roodman GD, Guise TA, Boyce BF, Brufsky AM, Clézardin P, Croucher PI, Gralow JR, Hadji P, Holen I, Mundy GR, Smith MR, Suva LJ. Coleman RE, et al. Among authors: clezardin p. Cancer Treat Rev. 2010 Dec;36(8):615-20. doi: 10.1016/j.ctrv.2010.04.003. Epub 2010 May 15. Cancer Treat Rev. 2010. PMID: 20478658 Free PMC article. Review.
Bisphosphonates in preclinical bone oncology.
Clézardin P, Benzaïd I, Croucher PI. Clézardin P, et al. Bone. 2011 Jul;49(1):66-70. doi: 10.1016/j.bone.2010.11.017. Epub 2010 Dec 8. Bone. 2011. PMID: 21145441 Review.
Lysophosphatidic acid receptor type 1 (LPA1) plays a functional role in osteoclast differentiation and bone resorption activity.
David M, Machuca-Gayet I, Kikuta J, Ottewell P, Mima F, Leblanc R, Bonnelye E, Ribeiro J, Holen I, Vales RL, Jurdic P, Chun J, Clézardin P, Ishii M, Peyruchaud O. David M, et al. Among authors: clezardin p. J Biol Chem. 2014 Mar 7;289(10):6551-6564. doi: 10.1074/jbc.M113.533232. Epub 2014 Jan 15. J Biol Chem. 2014. PMID: 24429286 Free PMC article.
Adjuvant bisphosphonates in early breast cancer: consensus guidance for clinical practice from a European Panel.
Hadji P, Coleman RE, Wilson C, Powles TJ, Clézardin P, Aapro M, Costa L, Body JJ, Markopoulos C, Santini D, Diel I, Di Leo A, Cameron D, Dodwell D, Smith I, Gnant M, Gray R, Harbeck N, Thurlimann B, Untch M, Cortes J, Martin M, Albert US, Conte PF, Ejlertsen B, Bergh J, Kaufmann M, Holen I. Hadji P, et al. Among authors: clezardin p. Ann Oncol. 2016 Mar;27(3):379-90. doi: 10.1093/annonc/mdv617. Epub 2015 Dec 17. Ann Oncol. 2016. PMID: 26681681 Free article. Review.
Bone metastases.
Coleman RE, Croucher PI, Padhani AR, Clézardin P, Chow E, Fallon M, Guise T, Colangeli S, Capanna R, Costa L. Coleman RE, et al. Among authors: clezardin p. Nat Rev Dis Primers. 2020 Oct 15;6(1):83. doi: 10.1038/s41572-020-00216-3. Nat Rev Dis Primers. 2020. PMID: 33060614 Review.
Bone metastasis: mechanisms, therapies, and biomarkers.
Clézardin P, Coleman R, Puppo M, Ottewell P, Bonnelye E, Paycha F, Confavreux CB, Holen I. Clézardin P, et al. Physiol Rev. 2021 Jul 1;101(3):797-855. doi: 10.1152/physrev.00012.2019. Epub 2020 Dec 24. Physiol Rev. 2021. PMID: 33356915 Free article. Review.
MicroRNAs and Their Roles in Breast Cancer Bone Metastasis.
Puppo M, Valluru MK, Clézardin P. Puppo M, et al. Among authors: clezardin p. Curr Osteoporos Rep. 2021 Jun;19(3):256-263. doi: 10.1007/s11914-021-00677-9. Epub 2021 Apr 8. Curr Osteoporos Rep. 2021. PMID: 33830428 Free PMC article. Review.
173 results